Poniard Pharmaceuticals Inc (PARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2001 | 12-2000 | 12-1999 | 12-1998 | 12-1997 | |
| Sales | 2,870 | 3,540 | 590 | 9,080 | 10,352 |
| Gross Profit | 2,870 | 3,540 | 590 | 9,080 | 10,352 |
| Operating Expenses | 29,010 | 21,580 | 15,350 | 14,710 | 0 |
| Operating Income | -26,140 | -18,040 | -14,760 | -5,630 | 10,352 |
| Interest Expense | 390 | 160 | 110 | 130 | 136 |
| Other Income | 2,730 | 6,800 | 2,920 | 1,320 | -12,766 |
| Pre-tax Income | -23,800 | -11,400 | -11,950 | -4,440 | -2,550 |
| Net Income Continuous | -23,802 | -11,402 | -11,951 | -3,790 | -2,550 |
| Net Income | $-23,800 | $-11,400 | $-11,950 | $-4,440 | $-2,550 |
| EPS Basic Total Ops | -220.76 | -119.98 | -141.57 | -57.59 | -74.38 |
| EPS Basic Continuous Ops | -216.38 | -114.71 | -136.43 | -43.51 | -33.86 |
| EPS Diluted Total Ops | -220.76 | -119.98 | -141.57 | -57.59 | -74.38 |
| EPS Diluted Continuous Ops | -216.38 | -114.71 | -136.43 | -43.51 | -33.86 |
| EBITDA(a) | $-24,800 | $-17,530 | $-14,410 | $-5,210 | $10,352 |